Research We Fund: Extramural Discovery Science (EDS)
We are the research-funding arm of the 绿帽社 (ACS).
Our grants fund high-impact and innovative cancer research conducted by hundreds of promising scientists and health care professionals - primarily early in their careers - at institutions across the United States.?
The funds that we use to support research grants are possible because of?generous donations to the ACS.
New Dates & Programs in 2025
Our Grant Calendars Are Changing
Update Your Calendar:?2025 Summer and Winter Grant Application Dates (PDF)
New EDS Program to Support Career Growth and Research Excellence
Get to Know the Updated EDS:
Studies Selected for Funding
We support independent investigators and offer mentored awards. Our funds support institutions, professors, and early-career scientists. We keep raising the bar with requests for applications (RFAs) for focused and pivotal topics.?
The ACS determines which studies to fund based on an extensive peer review process led by renowned medical professionals, research scholars, and ACS Community Research Partners volunteering their time.
This research funding strategy has helped support numerous important discoveries and some of the brightest researchers, including our ACS Professors and 52?Nobel Prize winners to date.?
It’s very exciting, as we fund studies that will increase our understanding of genetics and cancer risk and explore better ways to find, treat, and survive cancer, focusing on equity and optimizing quality of life for cancer survivors.”
Bill Dahut, MD
3 Former ACS Grantees Are Awarded the 2024 Nobel Prize
Victor Ambrose,?PhD?
Silverman Professor of Natural Science at the University of Massachusetts Medical School